Vir Biotechnology, Inc. — Director's Dealing 2020

May 5, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Vir Biotechnology, Inc. (VIR)
CIK: 0001706431
Period of Report: 2020-05-01

Reporting Person: MORE ROBERT J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-05-01	Common Stock	S	15758	$27.8995	Disposed	74234	Direct
2020-05-01	Common Stock	S	2700	$28.5972	Disposed	71534	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	972221	Indirect

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.51 to $28.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F2: Includes an estimated 29,170 shares received in a pro-rata distribution from Alta Partners NextGen Fund I, L.P. (APNG 1) initiated on April 29, 2020. The reporting person will file an amendment to this Form 4 if the final number of shares received by him in the distribution changes from the amount reported herein.

F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.51 to $28.675, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

F4: The shares are held by APNG 1. The reporting person is a managing director of Alta Partners NextGen Fund I Management, LLC, which is the general partner of APNG 1. As such, the reporting person may be deemed to beneficially own the shares held by APNG 1. However, the reporting person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed to be an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise. On April 29, 2020, APNG 1 effected, without consideration, a pro-rata in-kind distribution of 972,222 shares to its partners. In prior reports, the reporting person reported indirect beneficial ownership of 1,944,443 shares of the Issuer held by APNG 1.